Words by Jade Williams
GOLD looks back at some of the top news stories from the pharmaceutical industry over the last few months, including the latest standout drug approvals, philanthropic donations and much more
28 February
UK Department of Health and Social Care releases first annual Rare Diseases Action Plan
08 March
Johnson & Johnson’s COVID-19 vaccine first to be manufactured and made available by an African company
10 March
In support of Ukraine, EFPIA members donate five million medicine doses and €55m to NGOs
14 March
AstraZeneca and MSD’s Lynparza is first approved drug for BRCA mutations in early breast cancer
16 March
NICE publishes quality standard to improve diagnosis of foetal alcohol spectrum disorder
18 March
FDA approves BMS’s first-in-class treatment Opdualag for unresectable or metastatic melanoma
25 March
Jazz Pharmaceuticals announces plan to build manufacturing facility for regulatory-approved cannabis-based medicines
28 March
Gilead Sciences pledges $24m in grants to tackle health disparities between populations vulnerable to HIV
31 March
NICE recommends real-time continuous glucose monitoring for all people with type 1 diabetes for the first time
07 April
European Commission approves Sanofi’s Dupixent for six- to 11-year-olds with severe asthma
08 April
Gavi secures $4.8bn in funding pledges from world leaders for COVAX
11 April
EFPIA member companies commit to speedier European market launches to avert stricter regulation
This news round up features in GOLD 21 – read the full issue here.